CISTIC FIBROSIS NEWS TODAY - With the rising prevalence of superbugs, researchers are turning their attention to antibiotic molecules. Study co-authors Berthony Deslouches (EOH) and Ronald Montelaro (IDM) have engineered a cationic antimicrobial peptide named WLBU2, licensed by Pitt spin-off Peptilogics, that's now in a clinical trial for preventing infections associated with knee and hip replacements.
COVID-19 is one of three novel coronavirus outbreaks in the past 20 years that originated in animals. How is the current outbreak similar and different from the previous ones? What course will COVID-19 take in Pennsylvania? IDM's Amy Hartman puts the current outbreak in perspective with what we know (and don’t know) about SARS-CoV-2. EPI's Donald Burke discusses the epidemiological and environmental factors that will shape the likely ph...
NBC NEWS – IDM's Charles Rinaldo said that many have tried to come up with vaccines that use two or three proteins out of the approximately 75 that make up the virus. Those would be safe, but have not protected well. Another approach has been to use a weakened form of the whole virus. In that attenuated, its replication capacity is weakened but it’s not as safe. These failures “are why this is such a monster.”
SCIENCE - IDM's Douglas Reed, who is developing and testing COVID-19 vaccines in monkey studies, says the number of animals was too small to yield statistically significant results. His team also has a manuscript in preparation that raises concerns about the way the Sinovac team grew the stock of novel coronavirus used to challenge the animals: It may have caused changes that make it less reflective of the ones that infect humans.
SCIENCE – Dozens of research teams are racing to develop animal models that can help find effective COVID-19 vaccines and treatments. IDM’s Douglas Reed is staging experiments in air chambers that attempt to infect monkeys through this route, which both might increase pathogenicity and offer clues about transmission risks. He explains, “We’re trying to get enough virus into them to get some kind of disease.”
DISCOVER - As COVID-19 blasts across the globe, viral wellness videos and posts are springing up in its wake. But so far, says John Mellors, IDM professor and chief of infectious diseases at Pitt, no randomized clinical trials have shown vitamins or natural remedies to be effective in treating or preventing COVID-19. He adds, if you're already eating a balanced diet, suppliments probably aren’t going to juice your COVID-19 immunity.
UPMC – A new test for COVID-19 was created by a virology team including Charles Rinaldo, chair and professor of infectious diseases and microbiology and director of the UPMC Clinical Virology Laboratory. The health system plans to increase lab capacity and open testing sites around the state. The test follows U.S. CDC guidelines and was validated under the Clinical Laboratory Improvement Amendments program of the Centers for Medicare & Medicaid ...
WIRED - News reports detailing the case raised the possibility that people may not be developing immunity to the new coronavirus, even after they’ve recovered. But Donald Burke, dean emeritus and international infectious disease specialist, says there’s not enough data to support that conclusion. “The question is really: How good is the proof? And we’re a long way away from anything solid. What we need is the sequence of the virus.”
TRIB LIVE – Experts from multiple disciplines gather to discuss the outbreak of novel coronavirus COVID-19. Panelists include IDM’s Amy Hartman, who studies emerging viruses and diseases transmitted from animals to people and then among people; and ACHD medical epidemiologist Kristen Mertz, who also serves as an adjunct assistant professor at Pitt Public Health. “Information is coming out very quickly and it’s hard to … know the facts,” Hartman...
U.S. NEWS & WORLD REPORT - For more than three decades, Pitt Men’s Study leaders have gathered with Pittsburgh men and women to remember those who have died and give thanks for the 1,743 men who have participated in the nation’s longest-running HIV/AIDS research project. IDM's Charles Rinaldo has led the effort since the virus surfaced here in 1981. “We are still searching for a true vaccine to prevent HIV,” Rinaldo says. “But we are dedicated t...
TRIB LIVE - Physicians also need to be included in education around prescribing and using PrEP, said IDM's Linda Frank. That goes beyond making sure their patients take a pill a day. It includes working with communities to make sure people have the support and counseling to make healthy decisions. She said, “It’s important to have treatments and vaccines, but we still have to work on that other side of the equation: How do you get people to chan...
The Department of Infectious Diseases and Microbiology held their biggest-ever research day celebration, featuring three guest speakers: Jonathan Oliver spoke about the emerging tick-borne diseases of the northern United States, Daniel Voth talked about using human-derived systems to investigate bacterial pulmonary infection, and David Lampe lectured on inhibiting the spread of malaria by altering the mosquito microbiome.
INSIDE UPMC - Public health alumnae & RPCVs Marilyn Blasingame (IDM '16) and Ingrid Godfrey (IDM '18), and IDM professor Linda Rose Frank discuss their work on the prevention and treatment of HIV/AIDS and its co-morbidities through the MidAtlantic AIDS Education & Training Center (MAAETC), which recently was awarded $14.2 million from the Department of Health and Human Services to continue the center’s work for the next five years
THE NEW YORK TIMES - The virus has been out of the headlines, but that doesn't mean it is gone. The World Health Organization just updated guideines for travelling to the Zika zone. "Summer in the north is winter in the south and vice versa, so you have to consider that," said IDM's Ernesto Marques. The virus is still circulating, but it's less prevalent in colder months than in the summer.